BioSpace News Archive

Drug Development

Diartis, Inc. Presents VRS-859 (exenatide-XTEN) Interim Phase 1 Data for Type 2 Diabetes at American Diabetes Association Annual Scientific Meeting

June 27, 2011
·
2 min read
Drug Development

ERYtech Pharma Completes the Enrollment of Patients in Its Phase I Clinical Trial in Pancreatic Cancer

June 27, 2011
·
1 min read
Drug Development

Biota, Inc. Announces Preliminary Phase III Prophylaxis Trial Results for CS-8959

June 27, 2011
·
1 min read
Sunshine Biopharma, Inc.'s Lead Anti-Cancer Compound, Adva-27a, Performs Exceptionally Well in Human Microsome Stability Assays

June 27, 2011
·
1 min read
Biotech Bay

Titan Pharmaceuticals to Present at 2011 Biotechnology Industry Organization (BIO) International Convention

June 27, 2011
·
1 min read
Drug Development

Cellceutix Provides Updates on Kevetrin(TM), Cellceutix’s Novel Anti-Cancer Therapy

June 27, 2011
·
3 min read
BioMidwest

Medline Industries, Inc. Unveils Practical and Targeted Infection Control Interventions at Annual 2011 APIC Congress

June 27, 2011
·
2 min read
Drug Development

Novo Nordisk A/S Release: New Data Shows Victoza® Helped Reduce Blood Sugar When Patients With Type 2 Diabetes Switched From Sitagliptin or Exenatide

June 27, 2011
·
9 min read
Biotech Bay

VIVUS, Inc. Release: QNEXA® Data Featured at the American Diabetes Association’s 71st Scientific Sessions

June 27, 2011
·
7 min read
Drug Development

Nile Therapeutics, Inc. Provides Update on Ongoing Phase I Clinical Trial of Cenderitide

June 27, 2011
·
4 min read